In the aesthetic medicine sector, microneedles have rapidly evolved from a specialized therapeutic technology into a core engine driving market growth. With their precise positioning as a "minimally invasive skin rejuvenation" solution, they have unlocked a vast consumer market spanning professional clinics to home‑use scenarios, emerging as a standout track amid the boom of light aesthetic medicine.

The core working mechanism of microneedles in aesthetic medicine is collagen‑induction therapy. By creating controlled micro‑injuries, microneedles trigger the skin's self‑repair mechanism, stimulating massive synthesis of new collagen and elastin, thereby effectively ameliorating various skin concerns including acne scars, enlarged pores, skin laxity and fine lines. According to a report by Moland Intelligence, the global microneedle market reached USD 632 million in 2024 and is projected to expand continuously at a compound annual growth rate (CAGR) of 7.70%.

Market products are mainly categorized into two types: professional medical devices and home‑use consumer goods. In the professional device segment, radiofrequency (RF) microneedles (also known as gold microneedles) stand as a model of technological integration. Combining the physical stimulation of microneedles with the thermal effect of radiofrequency, they deliver a synergistic "1+1>2" outcome. They heat the dermis more deeply to boost collagen contraction and regeneration, showing particularly remarkable effects in skin tightening, anti‑aging and acne scar treatment. Domestic brands have gained momentum in this field: Peninsula Gold Microneedle by Shenzhen Peninsula Medical Group obtained US FDA 510(k) clearance in 2025, making it the first domestic RF microneedle device to receive such certification and marking the successful global expansion of high‑end Chinese‑manufactured aesthetic medical equipment. International brands including Israel‑based EndyMed, South Korea's INTRAcel and Sylfirm X also hold substantial market shares in China.

Another key technological pathway lies in dissolvable microneedle patches, which are emerging as a rising star for precision home skincare. These products integrate active ingredients such as hyaluronic acid and peptides directly into dissolvable microneedles, enabling pain‑free and efficient transdermal delivery of actives for at‑home users. Enterprises like Zhongke Microneedle provide technological and manufacturing support for numerous skincare brands via CRO/CMO/CDMO models for dissolvable microcrystal patches. Forecasts indicate the global cosmetic microneedle patch market will reach USD 761 million by 2031, with microcrystal eye patches targeting periorbital fine lines and nasolabial folds being the largest sub‑category.

Branded operation is equally critical in the aesthetic microneedle market. EVE CHARM, owned by Guangzhou Yuansheng Biotechnology Co., Ltd., is a pioneer of microneedle therapy in China and a key promoter of industry standards. Driven by the dual core of "AI synthetic biology + regenerative intelligent medicine", it has built a product portfolio ranging from microneedle therapy to exosome technology, representing the trend of aesthetic medical enterprises toward technologicalization and branding.

Beneath market growth lies profound shifts in consumer trends. Tencent's 2024 White Paper on Light Aesthetic Medicine Consumption Trends notes that light aesthetic medicine accounts for over half of the overall aesthetic medicine market. Featuring short recovery periods, definite treatment outcomes and relatively low risks, microneedle treatments perfectly align with modern consumers' pursuit of "efficient, convenient and safe" beauty enhancement. Meanwhile, popularization of cosmetic treatments via social media and growing demand for skin rejuvenation in an aging society jointly fuel the expansion of the microneedle market.

In the future, aesthetic microneedle technology will continue to advance toward combination therapy and intelligence. For instance, combining microneedles with platelet‑rich plasma (PRP), LED phototherapy and other technologies has become a mainstream solution to improve therapeutic efficacy. Intelligent microneedle devices integrated with sensors for precise energy regulation will further guarantee treatment safety and personalized results, consolidating microneedles' core position in the hundred‑billion‑yuan aesthetic medicine market.